Clinical Diagnostic Value of Serum GABA, NE, ET-1, and VEGF in Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension

References

• Labaki WW, Rosenberg SR. Chronic obstructive pulmonary disease. Ann Intern Med. 2020;173(3):Itc17–itc32. doi:10.7326/AITC202008040
   PubMed Web of Science ®Google Scholar
• Christenson SA, Smith BM, Bafadhel M, Putcha N. Chronic obstructive pulmonary disease. Lancet. 2022;399(10342):2227–2242. doi:10.1016/S0140-6736(22)00470-6
   PubMed Web of Science ®Google Scholar
• Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389(10082):1931–1940. doi:10.1016/S0140-6736(17)31222-9
   PubMed Web of Science ®Google Scholar
• Cassady SJ, Reed RM. Pulmonary hypertension in COPD: a case study and review of the literature. Medicina (Kaunas, Lithuania). 2019;55(8). doi:10.3390/medicina55080432
   PubMed Web of Science ®Google Scholar
• Nathan SD, Barbera JA, Gaine SP, et al. Pulmonary hypertension in chronic lung disease and hypoxia. Eur Respir J. 2019;53(1):1801914. doi:10.1183/13993003.01914-2018
   PubMed Web of Science ®Google Scholar
• Andersen K, Iversen M, Kjaergaard J, et al. Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease. J Heart Lung Transpl. 2012;31(4):373–380. doi:10.1016/j.healun.2011.11.020
   PubMed Web of Science ®Google Scholar
• Weitzenblum E, Hirth C, Ducolone A, Mirhom R, Rasaholinjanahary J, Ehrhart M. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax. 1981;36(10):752–758. doi:10.1136/thx.36.10.752
   PubMed Web of Science ®Google Scholar
• Oswald-Mammosser M, Weitzenblum E, Quoix E, et al. Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest. 1995;107(5):1193–1198. doi:10.1378/chest.107.5.1193
   PubMed Web of Science ®Google Scholar
• Bogaard HJ, Natarajan R, Mizuno S, et al. Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats. Am J Respir Crit Care Med. 2010;182(5):652–660. doi:10.1164/rccm.201003-0335OC
   PubMed Web of Science ®Google Scholar
• Suzuki R, Maehara R, Kobuchi S, Tanaka R, Ohkita M, Matsumura Y. Beneficial effects of γ-aminobutyric acid on right ventricular pressure and pulmonary vascular remodeling in experimental pulmonary hypertension. Life Sci. 2012;91:693–698. doi:10.1016/j.lfs.2012.04.006
   PubMed Web of Science ®Google Scholar
• Wang R, Zeng Q, Wang W, Wang W. GABA(A) and GABA(B) receptor-mediated inhibition of sympathetic outflow in the paraventricular nucleus is blunted in chronic heart failure. Clin Exp Pharmacol Physiol. 2009;36:516–522. doi:10.1111/j.1440-1681.2008.05101.x
   PubMed Web of Science ®Google Scholar
• Benza R, Gomberg-Maitland M, Demarco T, et al. Endothelin-1 pathway polymorphisms and outcomes in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2015;192(11):1345–1354. doi:10.1164/rccm.201501-0196OC
   PubMed Web of Science ®Google Scholar
• Dai Y, Chen X, Song X, et al. Immunotherapy of endothelin-1 receptor type A for pulmonary arterial hypertension. J Am Coll Cardiol. 2019;73(20):2567–2580. doi:10.1016/j.jacc.2019.02.067
   PubMed Web of Science ®Google Scholar
• Hwangbo C, Lee H-W, Kang H, et al. Modulation of endothelial bone morphogenetic protein receptor type 2 activity by vascular endothelial growth factor receptor 3 in pulmonary arterial hypertension. Circulation. 2017;135(23):2288–2298. doi:10.1161/CIRCULATIONAHA.116.025390
   PubMed Web of Science ®Google Scholar
• Wang YL. 慢性阻塞性肺疾病患者血清VEGF、bFGF水平与肺动脉高压的关系研究 [Relationship between serum VEGF and bFGF levels and pulmonary arterial hypertension in patients with chronic obstructive pulmonary disease]. J Clin Pulm Med. 2019;2019:849–852. Chinese.
   Google Scholar
• Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. doi:10.1183/13993003.00164-2019
   PubMed Web of Science ®Google Scholar
• 中华医学会心血管病学分会肺血管病学组;中华心血管病杂志编辑委员会. 中国肺高血压诊断和治疗指南2018 [Chinese guidelines for the diagnosis and treatment of pulmonary hypertension 2018]. Zhonghua xin xue guan bing za zhi. 2018;46(12):933–964. Chinese. doi:10.3760/cma.j.issn.0253-3758.2018.12.006
   PubMedGoogle Scholar
• Knight D, Ellison J, Hibbs R, Hyman A, Kadowitz P. A light and electron microscopic study of the innervation of pulmonary arteries in the cat. Anat Rec. 1981;201(3):513–521. doi:10.1002/ar.1092010308
   PubMedGoogle Scholar
• Ciarka A, Doan V, Velez-Roa S, Naeije R, van de Borne P. Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2010;181(11):1269–1275. doi:10.1164/rccm.200912-1856OC
   PubMed Web of Science ®Google Scholar
• Watanabe E, Ogawa K, Ban M, Satake T. Sympathetic nervous systems in chronic cor pulmonale. Jpn Circ J. 1981;45(6):646–653. doi:10.1253/jcj.45.646
   PubMedGoogle Scholar
• Nootens M, Kaufmann E, Rector T, et al. Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels. J Am Coll Cardiol. 1995;26(7):1581–1585. doi:10.1016/0735-1097(95)00399-1
   PubMed Web of Science ®Google Scholar
• Pepke-Zaba J, Higenbottam T, Dinh-Xuan A, Ridden C, Kealey T. Alpha-adrenoceptor stimulation of porcine pulmonary arteries. Eur J Pharmacol. 1993;235:169–175. doi:10.1016/0014-2999(93)90133-3
   PubMed Web of Science ®Google Scholar
• Richards A, Ikram H, Crozier I, Nicholls M, Jans S. Ambulatory pulmonary arterial pressure in primary pulmonary hypertension: variability, relation to systemic arterial pressure, and plasma catecholamines. Br Heart J. 1990;63(2):103–108. doi:10.1136/hrt.63.2.103
   PubMedGoogle Scholar
• Houweling B, Merkus D, Sorop O, Boomsma F, Duncker D. Role of endothelin receptor activation in secondary pulmonary hypertension in awake swine after myocardial infarction. J Physiol. 2006;574:615–626. doi:10.1113/jphysiol.2006.107060
   PubMed Web of Science ®Google Scholar
• Guo Q, Xu H, Yang X, et al. Notch activation of Ca-sensing receptor mediates hypoxia-induced pulmonary hypertension. Hypertens Res. 2017;40(2):117–129. doi:10.1038/hr.2016.118
   PubMed Web of Science ®Google Scholar
• Wang Z, Li A, Guo Q, et al. Effects of cyclic intermittent hypoxia on ET-1 responsiveness and endothelial dysfunction of pulmonary arteries in rats. PLoS One. 2013;8(3):e58078. doi:10.1371/journal.pone.0058078
   PubMed Web of Science ®Google Scholar
• Cotter D, Landau S, Beasley C, et al. The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. Biol Psychiatry. 2002;51(5):377–386. doi:10.1016/S0006-3223(01)01243-4
   PubMed Web of Science ®Google Scholar
• Barnes P, Liu S. Regulation of pulmonary vascular tone. Pharmacol Rev. 1995;47(1):87–131.
   PubMed Web of Science ®Google Scholar
• Adams P, Brown D. Actions of gamma-aminobutyric acid on sympathetic ganglion cells. J Physiol. 1975;250(1):85–120. doi:10.1113/jphysiol.1975.sp011044
   PubMed Web of Science ®Google Scholar
• Bowery N, Hudson A. Gamma-aminobutyric acid reduces the evoked release of [3H]-noradrenaline from sympathetic nerve terminals [proceedings]. Br J Pharmacol. 1979;66(1):108P.
   PubMed Web of Science ®Google Scholar
• Kenney M, Weiss M, Patel K, Wang Y, Fels R. Paraventricular nucleus bicuculline alters frequency components of sympathetic nerve discharge bursts. Am J Physiol Heart Circ Physiol. 2001;281(3):H1233–41. doi:10.1152/ajpheart.2001.281.3.H1233
   PubMed Web of Science ®Google Scholar
• Velez-Roa S, Ciarka A, Najem B, Vachiery J-L, Naeije R, van de Borne P. Increased sympathetic nerve activity in pulmonary artery hypertension. Circulation. 2004;110(10):1308–1312. doi:10.1161/01.CIR.0000140724.90898.D3
   PubMed Web of Science ®Google Scholar
• Lingeshwar P, Kaur G, Singh N, et al. A study on the involvement of GABA-transaminase in MCT induced pulmonary hypertension. Pulm Pharmacol Ther. 2016;36:10–21. doi:10.1016/j.pupt.2015.11.002
   PubMed Web of Science ®Google Scholar
• Chen S-L, Zhang -F-F, Xu J, et al. Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (First-in-Man Pulmonary Artery Denervation for Treatment of Pulmonary Artery Hypertension). J Am Coll Cardiol. 2013;62(12):1092–1100. doi:10.1016/j.jacc.2013.05.075
   PubMed Web of Science ®Google Scholar
• Huang Y, Liu YW, Xiang L, et al. 经胸肺动脉去神经支配术在肺动脉高压大鼠模型中的治疗作用[J].中国循环杂志 [Therapeutic Effects of Transthoracic Pulmonary Artery Denervation in a Rat Model of Pulmonary Arterial Hypertension]. Chin Circ J. 2018;12:616–620. Chinese.
   Google Scholar
• Ishikawa M, Sato N, Asai K, Takano T, Mizuno K. Effects of a pure alpha/beta-adrenergic receptor blocker on monocrotaline-induced pulmonary arterial hypertension with right ventricular hypertrophy in rats. Circ J. 2009;73(12):2337–2341. doi:10.1253/circj.CJ-09-0213
   PubMed Web of Science ®Google Scholar
• Chen G, Song J, Xiong H, Zhang L, Lv J. γ-氨基丁酸对肺动脉高压大鼠肺组织VEGF、MMP-9表达的影响[J].重庆医学 [Effect of GABA on expression of VEGA and MMP-9 in monocrotaline-induced pulmonary hypertension rats]. Chongqing Med J. 2014;36:4043–4045. Chinese.
   Google Scholar
• Suleiman S, Klassen S, Katz I, et al. Argon reduces the pulmonary vascular tone in rats and humans by GABA-receptor activation. Sci Rep. 2019;9(1):1902. doi:10.1038/s41598-018-38267-y
   PubMedGoogle Scholar
• Ma Z, Yu Y-R, Badea CT, et al. Vascular endothelial growth factor receptor 3 regulates endothelial function through β-Arrestin 1. Circulation. 2019;139(13):1629–1642. doi:10.1161/CIRCULATIONAHA.118.034961
   PubMed Web of Science ®Google Scholar